Medizone Home
×

Meet us at CPhI 2021 – Milan 9th to 11th November

We are looking forward to meet you at CPhI Milan from the 9th to 11th November 2021 – please contact Mr. Robin Mangler - Head of International Pharma Sales - robin.mangler@medizone.com Mr. Klajdi Drini - ...

Thanks for visiting us at Expopharm 2018!

Thank you for visiting us at Expopharm in Munich this year. It was a great pleasure to have the opportunity again to speak in person with many of our business partners. One big subject was the safety of ...

CHMP approves pegfilgrastim biosimilar, Pelgraz from Accord/Intas

Pelgraz – a pegylated G-CSF biosimilar, is latest addition to Accord Healthcare’s established portfolio of over 30 oncology treatments across Europe. Following marketing authorisation Accord Healthcare ...

FDA approves Mylan and Biocon’s Fulphila, the first biosimilar to Neulasta

Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Mylan’s Fulphila (pegfilgrastim-jmbd), a biosimilar to Neulasta (pegfilgrastim), co-developed with ...